#Mguard v11 trial#
#Mguard v11 download#
#Mguard v11 free#

You don't have to fax or email MSDS sheets anymore, just send whoever you want to your online MSDS binder using your personal URL address.

#Mguard v11 download#

Your employees, customers and shipping agents can view, print, or download any of the MSDS sheets included in your online MSDS binder using a desktop, laptop, tablet or smartphone. We've included the most sought after safety data sheets, and the database just keeps growing.Īs a registered user in our community, you can add any of the records we've included in our database to your online digital binder and even upload any MSDS sheets you might already have to create your own custom msds database that you can share with your employees or customers. Our MSDS database is an easy to use, do it yourself tool, and best of all. Other companies are charging thousands of dollars to set up accounts and give you access to their msds online database. Your new online MSDS binder is a place for you to store the material safety data sheets you need to deploy.

#Mguard v11 free#

Source: Inspire MD, Inc.Register now and get a free online MSDS binder. Although we are still working on the necessary approvals to resume our MASTER II FDA trial, we can immediately begin accelerating other important clinical programs while we simultaneously reengage our commercial customers.”

We expect production of the MGuard Prime EPS to ramp over the next several weeks, as we come back online to support our sales and clinical programs. Company commentsĪlan Milinazzo, CEO of InspireMD, stated, “We are pleased to report the approval of our modified manufacturing process for the MGuard Prime EPS and that we can now return to commercial and clinical activities in Europe and other markets outside of the U.S. In the meantime, the Company intends to continue focusing on site activation in order to accelerate enrollment once the study resumes.

#Mguard v11 trial#

The Company anticipates a late Q3 or early Q4 agency review and intends to resume enrollment in its MASTER II FDA trial shortly after regulatory approval is obtained. FDA approval of the manufacturing process changes to the MGuard Prime EPS. Inspire MD, having identified the root cause of these dislodgements needed to seek and gain approval from the European regulatory agency to modify all existing units of the Mguard Prime EPS in order to improve stent retention and performance, approval which it has now duly received. There have been no reports of any patients being actually harmed in the reported events.

The failures that prompted the recall of MGuard Prime EPS primarily occurred during the preparation of the Mguard Prime EPS, upon removal of the protective sleeve or during withdrawal of the Mguard Prime EPS into the guide catheter. The Company also received approval to modify and re-deploy existing MGuard Prime EPS stents that have been returned by clinical and commercial sites worldwide. Now it has issued a press release confirming receipt of European approval to resume the manufacturing of its MGuard Prime EPS stent with a modified stent securement process. In April of this year the company initiated a Voluntary Field Recall of its Mguard Prime EPS following reports of stent dislodgements.

We’ve been following InspireMD, Inc., with its clever MGuard embolic protection stent (EPS) technology, for a few years now.